Andrew Singleton

89.2k citations
339 papers · 25.3k · 12 hit papers · h-index 75

Impact in

  • Neurology top 0.01%
    • Parkinson's Disease Mechanisms and Treatments
    • Neurological diseases and metabolism
    • Neurological disorders and treatments
    • Nuclear Receptors and Signaling
    • Genetic Neurodegenerative Diseases

Papers in

    • Parkinson's Disease Mechanisms and Treatments 143
    • Neurological diseases and metabolism 57
    • Neurological disorders and treatments 29

Andrew Singleton

333 papers receiving 24.6k citations

Andrew Singleton's Hit Papers

A cross‐sectional study of α‐synuclein seed amplification assay in Alzheimer's disease neuroimaging initiative: Prevalence and associations with Alzheimer's disease biomarkers and cognitive function 2024 · 42 citations
420+7+14Years since publication50010001.5k

Peers

Andrew Singleton
Comparison fields: 5 of 188
  • Neurology 12.3k
  • Neurology 4.5k
  • Cellular and Molecular Neuroscience 5.9k
  • Physiology 4.9k
  • Aging 338
Replace Mark Cookson with:
Mark Cookson United States
Leonard Petrucelli United States
Gen Sobue Japan
Guy A. Rouleau Canada
Christine Klein Germany
Yoshikuni Mizuno Japan
Ryōsuke Takahashi Japan
Matthew J. Farrer United States
Henry Houlden United Kingdom
Pamela J. Shaw United Kingdom
Andrew Singleton relative to Mark Cookson United States Mark Cookson's profile →
Citations per field
00.5×1.5×
Mark Cookson · 1×
Citations per year

Countries citing papers authored by Andrew Singleton

Since Specialization
Citations

This map shows the geographic impact of Andrew Singleton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Singleton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Singleton more than expected).

Fields of papers citing papers by Andrew Singleton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Singleton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Singleton. The network helps show where Andrew Singleton may publish in the future.

Co-authors

The 25 scholars most cited alongside Andrew Singleton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Andrew Singleton Line = papers co-authored together Andrew Singleton links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 339 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Cloning of the Gene Containing Mutations that Cause PARK8-Linked Parkinson's Disease
Hit paper breakdown →
20041938
2
A meta-analysis of genome-wide association studies identifies 17 new Parkinson's disease risk loci
Hit paper breakdown →
2017813
3
The genetic architecture of Parkinson's disease
Hit paper breakdown →
2019733
4
Kinase activity is required for the toxic effects of mutant LRRK2/dardarin
Hit paper breakdown →
2006612
5
A common LRRK2 mutation in idiopathic Parkinson's disease
Hit paper breakdown →
2005611
6
Abundant Quantitative Trait Loci Exist for DNA Methylation and Gene Expression in Human Brain
Hit paper breakdown →
2010557
7
Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease
Hit paper breakdown →
2009543
8
Genomewide Association Studies and Human Disease
Hit paper breakdown →
2009537
9 1997499
10 2008416
11
Targeting α-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerations
Hit paper breakdown →
2015411
12 2001404
13 2008363
14 2005362
15 2016346
16 2016341
17 2009333
18 2011313
19 2006301
20 2012299

About Andrew Singleton

Andrew Singleton is a scholar working on Neurology, Molecular Biology, Cellular and Molecular Neuroscience, Neurology and Genetics, having authored 339 papers that have together received 25.3k indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (143 papers), Neurological diseases and metabolism (57 papers), Nuclear Receptors and Signaling (40 papers), Genetic Associations and Epidemiology (34 papers), Genetic Neurodegenerative Diseases (34 papers), Neurological disorders and treatments (29 papers), Alzheimer's disease research and treatments (27 papers) and Lysosomal Storage Disorders Research (18 papers). The work is most often cited by research in Neurology (12.3k citations), Neurology (4.5k citations), Cellular and Molecular Neuroscience (5.9k citations), Physiology (4.9k citations) and Aging (338 citations). Andrew Singleton has collaborated with scholars based in United States, United Kingdom and Italy. Frequent co-authors include John Hardy, Mike A. Nalls, Dena Hernández, Mark Cookson, Cornelis Blauwendraat, Coro Paisán-Ruı́z, Henry Houlden, Katrina Gwinn, J. Raphael Gibbs and Andrew J. Lees. Their work appears in journals such as Movement Disorders, Neurobiology of Aging, Annals of Neurology, Neurology and Human Molecular Genetics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact